Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
Title:
Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial
Author:
Agarwal, Neeraj Azad, Arun A Carles, Joan Fay, Andre P Matsubara, Nobuaki Heinrich, Daniel Szczylik, Cezary De Giorgi, Ugo Young Joung, Jae Fong, Peter C C Voog, Eric Jones, Robert J Shore, Neal D Dunshee, Curtis Zschäbitz, Stefanie Oldenburg, Jan Lin, Xun Healy, Cynthia G Di Santo, Nicola Zohren, Fabian Fizazi, Karim